Inhibition Of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor a

M. SALATINO, R. SCHILLCI, C. PROIETTI, R. CARNEVALE, I. FRAHM, A. MOLINOLO, A. IRIBARREN, E. CHARREAU Y P. ELIZALDE

ONCOGENE

Año: 2004 vol. 23 p. 5161 - 5174

0950-9232